PubAg

Main content area

Biological Activities of Xanthatin from Xanthium strumarium Leaves

Author:
Nibret, Endalkachew, Youns, Mahamoud, Krauth‐Siegel, R. Luise, Wink, Michael
Source:
Phytotherapy research 2011 v.25 no.12 pp. 1883-1890
ISSN:
0951-418X
Subject:
DNA, Trypanosoma brucei, Xanthium strumarium, anti-inflammatory activity, apoptosis, bloodstream forms, bromides, cell proliferation, diminazene, inflammation, leaves, leukemia, mechanism of action, parasites, trypanosomiasis
Abstract:
The objective of the present work was to evaluate the biological activities of the major bioactive compound, xanthatin, and other compounds from Xanthium strumarium (Asteraceae) leaves. Inhibition of bloodstream forms of Trypanosoma brucei brucei and leukaemia HL‐60 cell proliferation was assessed using resazurin as a vital stain. Xanthatin was found to be the major and most active compound against T. b. brucei with an IC50 value of 2.63 µg/mL and a selectivity index of 20. The possible mode of action of xanthatin was further evaluated. Xanthatin showed antiinflammatory activity by inhibiting both PGE2 synthesis (24% inhibition) and 5‐lipoxygenase activity (92% inhibition) at concentrations of 100 µg/mL and 97 µg/mL, respectively. Xanthatin exhibited weak irreversible inhibition of parasite specific trypanothione reductase. Unlike xanthatin, diminazene aceturate and ethidium bromide showed strong DNA intercalation with IC50 values of 26.04 µg/mL and 44.70 µg/mL, respectively. Substantial induction of caspase 3/7 activity in MIA PaCa‐2 cells was observed after 6 h of treatment with 100 µg/mL of xanthatin. All these data taken together suggest that xanthatin exerts its biological activity by inducing apoptosis and inhibiting both PGE2 synthesis and 5‐lipoxygenase activity thereby avoiding unwanted inflammation commonly observed in diseases such as trypanosomiasis.
Agid:
531118